"PrognosDx Health, Inc. - Product Pipeline Analysis, 2014 Update" Published
PrognosDx Health, Inc. (PrognosDx) is a biotechnology company. The company develops products for the treatment of cancer and other complex diseases. Its products include prognoscore and rxscore. PrognosDx's prognoscore is used in the treatment of prostate cancer and bladder cancer. The company's rxscore is a therapeutic test for pancreatic, breast, colorectal, and lung cancers. The company conducts clinical validation studies at medical centers throughout the US. PrognosDx is headquartered in Palo Alto, California, the US.
View full press release